# Macrolux

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/macrolux

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.microlite.cn
- Total disclosed funding: $29M
- Latest round: Series B (Oct 23, 2024)
- Investors on record: 3

## About

Established in 2020 and based in Shenzhen, China, Macrolux operates as a medical technology company that focuses on providing endoscopic interventional diagnosis and treatment business. The founder team employees have more than 10 years of working experience in endoscope product research and development, marketing, and production management. The company has a 100,000-level clean factory and electronic production workshop that meets GMP (Good Manufacturing Practice) requirements. In October 2024, Macrolux raised a series B funding for over CNY 100 million.

The company has 4 product pipelines, which are targeted at urology, pneumology, gynaecology, and gastroenterology. Products include CoralView Single-Use Digital Flexible Ureteroscope, ViewHub Image Processing Host, and LoopView Single-Use Digital Flexible Bronchoscope, etc. The company's products are exported to the United States, Germany, Singapore, Turkey, Japan, and South Korea.

The company generates revenue by selling endoscopic interventional diagnosis and treatment products.

The company will use the series B funding to expand production capacity, develop products, and expand global markets.

## Funding rounds

- Series B, Oct 23, 2024, $14M — Legend Capital, YuanBio Venture, Dalton Venture
- Series A, Jan 15, 2024 — Legend Capital, Dalton Venture
- Series A, Feb 8, 2023, $15M — Legend Capital, Dalton Venture

## Investors

- Legend Capital — Series A, Series B
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A, Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B